Cargando…

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Letko, Michael, Marzi, Andrea, Munster, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095430/ https://www.ncbi.nlm.nih.gov/pubmed/32094589 http://dx.doi.org/10.1038/s41564-020-0688-y

Ejemplares similares

Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses
por: Gu, Haogao, et al.
Publicado: (2020)

Studying Evolutionary Adaptation of MERS-CoV
por: Letko, Michael, et al.
Publicado: (2019)

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
por: Napolitano, Valeria, et al.
Publicado: (2022)

Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins
por: Tajuelo, Ana, et al.
Publicado: (2022)

Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS‐CoV‐2 mitigation strategies
por: Lopes, Elisson N., et al.
Publicado: (2021)

Intragenomic rearrangements involving 5′-untranslated region segments in SARS-CoV-2, other betacoronaviruses, and alphacoronaviruses
por: Patarca, Roberto, et al.
Publicado: (2023)

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2020)

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2021)

SARS-CoV-2 as a betacoronavirus comprises five structural proteins?
por: Zandi, Milad, et al.
Publicado: (2021)

A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions
por: Laing, Eric, et al.
Publicado: (2020)

SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world()
por: Ar Gouilh, Meriadeg, et al.
Publicado: (2018)

Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress
por: Bracquemond, David, et al.
Publicado: (2021)

Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses (SARS‐CoV‐1 and SARS‐CoV‐2)
por: Rombel‐Bryzek, Agnieszka, et al.
Publicado: (2022)

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses
por: Wen, Yingfen, et al.
Publicado: (2023)

The Omicron Lineages BA.1 and BA.2 (Betacoronavirus SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub
por: Lamarca, Alessandra P., et al.
Publicado: (2023)

Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor
por: Yousefi, Meisam, et al.
Publicado: (2023)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs
por: Pontes, Camila, et al.
Publicado: (2021)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
por: Benlarbi, Mehdi, et al.
Publicado: (2022)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
por: Laing, Eric D., et al.
Publicado: (2020)

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
por: Barthe, Manon, et al.
Publicado: (2023)

NMR study of macro domains (MDs) from betacoronavirus: backbone resonance assignments of SARS–CoV and MERS–CoV MDs in the free and the ADPr-bound state
por: Tsika, Aikaterini C., et al.
Publicado: (2021)

2019_nCoV/SARS‐CoV‐2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses
por: Wassenaar, T.M., et al.
Publicado: (2020)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses
por: Earnest, Rebecca, et al.
Publicado: (2023)

Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling
por: Yap, Yee Leng, et al.
Publicado: (2003)

SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells
por: Nguyen, Long C., et al.
Publicado: (2022)

Betacoronavirus(‡): Coronaviridae
por: Decaro, Nicola
Publicado: (2011)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

SARS-CoV-2, Early Entry Events
por: Chambers, James P., et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 entry into cells
por: Jackson, Cody B., et al.
Publicado: (2021)

Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
por: Sidarovich, Anzhalika, et al.
Publicado: (2022)

Adaptive Evolution of MERS-CoV to Species Variation in DPP4
por: Letko, Michael, et al.
Publicado: (2018)

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
por: Dispinseri, Stefania, et al.
Publicado: (2022)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hh0kqii0avhs3i1f1nvqmenmjs